Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

CXCR4-Expressing Anti-CD25 CAR T-Cells Effectively Eliminate Human AML Cells In Vivo

Ari Itoh-Nakadai, PhD, Yoriko Saito, MD, Mariko Murasawa-Tomizawa, Hiroshi Kajita, Takehisa Matsumoto, PhD, Masashi Matsuda, PhD, Takashi Watanabe, PhD, Mikako Shirouzu, Osamu Ohara, PhD, Haruhiko Koseki, MD PhD, Leonard Shultz, PhD, Fumihiko Ishikawa, MDPhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-142228

Published: 2020

Journal Articles

Targeting Critical Kinases and Anti-Apoptotic Molecules Overcomes Steroid Resistance in Infant MLL-Rearranged Leukemia

Anne Pieta De Groot, Yoriko Saito, MD, Eiryo Kawakami, Mari Hashimoto, Yuki Aoki, Rintaro Ono, MD PhD, Ikuko Ogahara, Saera Fujiki, Akiko Kaneko, Takashi Watanabe, PhD, Masatoshi Takagi, MD PhD, Daisuke Tomizawa, MD PhD, Katsuyoshi Koh, MD, Mariko Eguchi, MD, Eiichi Ishii, MD PhD, Osamu Ohara, Leonard Shultz, PhD, Shuki Mizutani, Fumihiko Ishikawa, MD PhD

Blood (2019) 134 (Supplement_1): 3885.

https://doi.org/10.1182/blood-2019-129719

Published: 2019

Journal Articles

Membrane-Bound Human Stem Cell Factor Promotes Differentiation of Human Granulocytes and Mast Cells In Vivo,

Shinsuke Takagi, MD, Yoriko Saito, MD, Atsushi Hijikata, PhD, Satoshi Tanaka, Takashi Watanabe, PhD, Haruhiko Koseki, MD, PhD, Osamu Ohara, PhD, Takashi Saito, PhD, Shuichi Taniguchi, MD, PhD, Leonard Shultz, PhD, Fumihiko Ishikawa, MD, PhD

Blood (2011) 118 (21): 3419.

https://doi.org/10.1182/blood.V118.21.3419.3419

Published: 2011

Journal Articles

Cell Cycle Entry Potentiates Elimination of Chemotherapy-Resistant Human AML Stem Cells.

Yoriko Saito, MD, Naoyuki Uchida, MD, PhD, Satoshi Tanaka, Mariko Tomizawa-Murasawa, Nahoko Suzuki, Shinsuke Takagi, MD, Yuho Najima, MD, Yuki Aoki, MD, Akiko Sone, Atsushi Wake, MD, Shuichi Taniguchi, MD, PhD, Leonard D. Shultz, PhD, Fumihiko Ishikawa, MD, PhD

Blood (2009) 114 (22): 1422.

https://doi.org/10.1182/blood.V114.22.1422.1422

Published: 2009

Journal Articles

Analysis of Idiopathic Myelofibrosis Initiating Cell in NOD/SCID/IL2rgKO Mice

Noriyuki Saito, MD, Fumihiko Ishikawa, MD, PhD, Kazuya Shimoda, MD, PhD, Shuro Yoshida, MD, PhD, Yoriko Saito, MD, Mitsuhiro Fukata, MD, Chika Iwamoto, Noriaki Kawano, MD, PhD, Leonard Shultz, PhD, Mine Harada, MD, Koichi Akashi, MD, PhD

Blood (2008) 112 (11): 3715.

https://doi.org/10.1182/blood.V112.11.3715.3715

Published: 2008

Journal Articles

Transplantation of Primary Human CD34+CD38 - Hematopoietic Stem Cells Recapitulates Idiopathic Myelofibrosis in the NOD/scid/IL2rgKO Mice.

Noriyuki Saito, MD, Fumihiko Ishikawa, MD/PhD, Kazuya Shimoda, MD/PhD, Shuro Yoshida, MD/PhD, Yoriko Saito, MD, Mitsuhiro Fukata, MD, Noriaki Kawano, MD/PhD, Leonard D. Shulz, PhD, Koichi Akashi, MD/PhD, Mine Harada, MD

Blood (2007) 110 (11): 260.

https://doi.org/10.1182/blood.V110.11.260.260

Published: 2007

Journal Articles

Establishment of Novel Disease Models for Human Acute Type ATL and HTLV-I Carrier Using NOD-scid/IL2rg null Mouse.

Chika Iwamoto, Fumihiko Ishikawa, MD, PhD, Noriaki Kawano, MD, PhD, Noriyuki Saito, MD, Shen M. Yang, MD, PhD, Mitsuhiro Fukata, MD, Yoriko Saito, MD, PhD, Leonard D. Shultz, PhD, Masao Matsuoka, MD, PhD, Mine Harada, MD, PhD

Blood (2007) 110 (11): 2797.

https://doi.org/10.1182/blood.V110.11.2797.2797

Published: 2007

Journal Articles

Human AML Stem Cells Remain Quiescent and Exhibit Chemotherapy Resistance within the Bone Marrow Endosteal Region.

Yoriko Saito, MD, Shuro Yoshida, MD/PhD, Noriyuki Saito, MD, Mitsuhiro Fukata, MD, Hidetoshi Ozawa, MSc, Takehiko Doi, MD/PhD, Toshihiro Miyamoto, MD/PhD, Koichi Ohshima, MD/PhD, Naoyuki Uchida, MD/PhD, Shuichi Taniguchi, MD/PhD, Koichi Akashi, MD/PhD, Mine Harada, MD, Leonard D. Shultz, PhD, Fumihiko Ishikawa, MD/PhD

Blood (2007) 110 (11): 780.

https://doi.org/10.1182/blood.V110.11.780.780

Published: 2007

Journal Articles

Xenotransplantation of Primary CD34+CD38- Hematopoietic Stem Cells Results in an In Vivo Model of Idiopathic Myelofibrosis.

Noriyuki Saito, MD, Fumihiko Ishikawa, MD/PhD, Kazuya Shimoda, MD/PhD, Shuro Yoshida, MD/PhD, Yoriko Saito, MD, Noriaki Kawano, MD/PhD, Leonard D. Shulz, PhD, Koichi Akashi, MD/PhD, Mine Harada, MD

Blood (2006) 108 (11): 666.

https://doi.org/10.1182/blood.V108.11.666.666

Published: 2006

Journal Articles

Nucleotide Receptor P2Y14 Modulates Hematopoietic Stem Cell Response to Tissue Injury Altering Stem Cell Preservation and Tissue Recovery.

Yoriko Saito, MD, Eyal Attar, MD, Samyukta Jana, BS, David Dombkowski, BS, Viktor Janzen, MD, Byeong-Chel Lee, PhD, Alastair D. Morrison, PhD, Alejandro Abuin, PhD, Sue Pickering, PhD, George P. Livi, PhD, Gregor B. Adams, PhD, David T. Scadden, MD

Blood (2006) 108 (11): 679.

https://doi.org/10.1182/blood.V108.11.679.679

Published: 2006

Journal Articles

Off-Label Use of Recombinant FVIIa: Clinical Characteristics That May Influence Outcomes.

Yoriko Saito, MD, Brian Healy, ScB, Richard M. Kaufman, MD, Walter H. Dzik, MD

Blood (2005) 106 (11): 431.

https://doi.org/10.1182/blood.V106.11.431.431

Published: 2005

NARROW

CXCR4-Expressing Anti-CD25 CAR T-Cells Effectively Eliminate Human AML Cells In Vivo

Targeting Critical Kinases and Anti-Apoptotic Molecules Overcomes Steroid Resistance in Infant MLL-Rearranged Leukemia

Membrane-Bound Human Stem Cell Factor Promotes Differentiation of Human Granulocytes and Mast Cells In Vivo,

Cell Cycle Entry Potentiates Elimination of Chemotherapy-Resistant Human AML Stem Cells.

Analysis of Idiopathic Myelofibrosis Initiating Cell in NOD/SCID/IL2rgKO Mice

Transplantation of Primary Human CD34+CD38 - Hematopoietic Stem Cells Recapitulates Idiopathic Myelofibrosis in the NOD/scid/IL2rgKO Mice.

Establishment of Novel Disease Models for Human Acute Type ATL and HTLV-I Carrier Using NOD-scid/IL2rg null Mouse.

Human AML Stem Cells Remain Quiescent and Exhibit Chemotherapy Resistance within the Bone Marrow Endosteal Region.

Xenotransplantation of Primary CD34+CD38- Hematopoietic Stem Cells Results in an In Vivo Model of Idiopathic Myelofibrosis.

Nucleotide Receptor P2Y14 Modulates Hematopoietic Stem Cell Response to Tissue Injury Altering Stem Cell Preservation and Tissue Recovery.

Off-Label Use of Recombinant FVIIa: Clinical Characteristics That May Influence Outcomes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only